ATE7689T1 - 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel. - Google Patents

1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.

Info

Publication number
ATE7689T1
ATE7689T1 AT81850117T AT81850117T ATE7689T1 AT E7689 T1 ATE7689 T1 AT E7689T1 AT 81850117 T AT81850117 T AT 81850117T AT 81850117 T AT81850117 T AT 81850117T AT E7689 T1 ATE7689 T1 AT E7689T1
Authority
AT
Austria
Prior art keywords
sup
sub
group
derivatives
preparation
Prior art date
Application number
AT81850117T
Other languages
English (en)
Inventor
Otto Agne Olsson
Leif Ake Svensson
Kjell Ingvar Leopold Wetterlin
Original Assignee
Aktiebolaget Draco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Draco filed Critical Aktiebolaget Draco
Application granted granted Critical
Publication of ATE7689T1 publication Critical patent/ATE7689T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/34—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton and at least one hydroxy group bound to another carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
AT81850117T 1980-07-09 1981-06-30 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel. ATE7689T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8022439 1980-07-09
GB8116441 1981-05-29
EP81850117A EP0043807B1 (de) 1980-07-09 1981-06-30 1-(Dihydroxyphenyl)-2-amino-äthanol-Derivate, Verfahren und Mittel zu ihrer Herstellung sowie diese Derivate enthaltende Mittel

Publications (1)

Publication Number Publication Date
ATE7689T1 true ATE7689T1 (de) 1984-06-15

Family

ID=26276161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81850117T ATE7689T1 (de) 1980-07-09 1981-06-30 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.

Country Status (29)

Country Link
US (2) US4419364A (de)
EP (1) EP0043807B1 (de)
KR (3) KR850000301B1 (de)
AT (1) ATE7689T1 (de)
AU (1) AU539976B2 (de)
CA (1) CA1180021A (de)
CS (1) CS221845B2 (de)
CY (1) CY1273A (de)
DD (1) DD202001A5 (de)
DE (1) DE3163871D1 (de)
DK (1) DK157678C (de)
ES (3) ES503768A0 (de)
FI (1) FI73666C (de)
GR (1) GR74291B (de)
HK (1) HK5385A (de)
HU (2) HU184959B (de)
IE (1) IE51373B1 (de)
IS (1) IS1262B6 (de)
LU (1) LU88304I2 (de)
MX (1) MX9203239A (de)
MY (1) MY8700026A (de)
NO (2) NO152130C (de)
NZ (1) NZ197628A (de)
PH (2) PH16535A (de)
PL (1) PL128513B1 (de)
PT (1) PT73336B (de)
SG (1) SG79784G (de)
SU (1) SU1128830A3 (de)
YU (3) YU42116B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904064D0 (sv) * 1989-12-01 1989-12-01 Astra Ab Improved method of preparing an intermediate for the manufacture of bambuterol
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US5830422A (en) * 1995-06-23 1998-11-03 Ormiston Mining And Smelting Co. Ltd. Method for production of sodium bicarbonate, sodium carbonate and ammonium sulfate from sodium sulfate
CA2247953A1 (en) * 1996-01-29 1997-07-31 E. Charles Pesterfield Jr. Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
KR20030085658A (ko) * 2002-04-30 2003-11-07 한올제약주식회사 밤부테롤의 개선된 합성방법
US7495028B2 (en) * 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
JP4979889B2 (ja) * 2002-08-08 2012-07-18 タン，ダブリュー． Ｒ型バンブテロール又はその薬学的に許容される塩の製造方法
AU2004268847A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
EP1694655A2 (de) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesteraseinhibitoren
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090054382A1 (en) * 2005-10-19 2009-02-26 Abhijit Ray Compositions of phosphodiesterase type iv inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
JP5399902B2 (ja) 2006-08-22 2014-01-29 ランバクシー ラボラトリーズ リミテッド マトリックスメタロプロテイナーゼ阻害剤
BRPI0717058A2 (pt) * 2006-09-22 2013-10-15 Ranbaxy Lab Ltd Composto, composição farmacêutica, método para tratar, prevenir, inibir ou suprimir uma condição inflamatória ou doença ou doenças do sistema nervoso central e método para a preparação de um composto
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern
WO2012014114A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
CA2812319A1 (en) 2010-09-24 2012-03-29 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
AP2015008444A0 (en) 2012-12-03 2015-05-31 Pfizer Novel selective androgen receptor modulators
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN104557614B (zh) * 2014-12-15 2017-01-04 广东东阳光药业有限公司 一种胺的还原方法
CN105622461B (zh) * 2016-01-29 2018-06-19 华南理工大学 一种化合物及其制备方法与应用
CN105859589B (zh) * 2016-04-05 2018-09-28 深圳市康立生生物科技有限公司 一种制备班布特罗杂质c的方法
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
CN109942462B (zh) * 2019-03-06 2022-01-14 宏冠生物药业有限公司 一种盐酸班布特罗的合成工艺
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE178032C1 (de) 1961-01-01
DE1643488U (de) 1949-11-28 1952-09-11 G E Hilge Fa Brutgeraet.
DK85789C (da) 1955-07-05 1958-06-30 Cilag Ag Fremgangsmåde til fremstilling af d,1- eller 1-isopropyl-aminometyl-(3,4-dihydroksy-fenyl)-karbinol eller salte deraf.
DE1768167U (de) 1958-04-02 1958-06-04 Artur O Herrmann Warngeraet bei strassenhindernissen.
DE1275069B (de) 1960-02-15 1968-08-14 Boehringer Sohn Ingelheim 1-(3', 5'-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoalkane und Verfahren zu ihrer Herstellung
NL123439C (de) 1961-09-14
FR1324857A (fr) * 1962-06-14 1963-04-19 Chemie Linz Ag Procédé pour la préparation de dérivés de la phényléthanolamine
GB1141606A (en) 1965-04-12 1969-01-29 Rech S Et D Applic Scient Et M Improvements in alkyl ethers of substituted phenylaminoethanols
DE1543372A1 (de) 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen
SE358633B (de) 1966-10-19 1973-08-06 Draco Ab
US3937838A (en) * 1966-10-19 1976-02-10 Aktiebolaget Draco Orally active bronchospasmolytic compounds and their preparation
SE335359B (de) 1966-10-19 1971-05-24 Draco Ab
NO132866C (de) 1966-10-19 1976-01-21 Draco Ab
FR6087M (de) 1967-01-10 1968-06-04
SE369299B (de) 1967-10-18 1974-08-19 Draco Ab
SE338324B (de) 1967-12-19 1971-09-06 Haessle Ab
NO129903B (de) 1969-04-01 1974-06-10 Sterling Drug Inc
AT294046B (de) 1969-07-08 1971-11-10 Chemie Linz Ag Verfahren zur Herstellung des N,N'-Bis[2-(3',4'-dihydroxyphenyl)-2-hydroxyäthyl]-hexamethylendiamins, seiner optisch aktiven Formen und der Salze derselben
US3657319A (en) * 1970-05-05 1972-04-18 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols
NO126437B (de) 1970-08-05 1973-02-05 Draco Ab
NL7112938A (de) 1970-09-30 1972-04-05
CH550771A (de) 1970-10-30 1974-06-28 Hoffmann La Roche Verfahren zur herstellung von phenaethylaminderivaten.
US3876679A (en) 1970-12-09 1975-04-08 Aldrich Chem Co Inc Di-substituted phenethylcarbamic acid esters
NL7213759A (de) 1971-10-19 1973-04-25
US4011258A (en) 1973-06-21 1977-03-08 Aktiebolaget Draco Orally active bronchospasmolytic compounds
FI56673C (fi) 1974-03-29 1981-02-04 Huhtamaeki Yhthymae Oy Nytt foerfarande foer framstaellning av alfa-tert-bytylaminometyl-4-hydroxy-m-xylen-alfa1 alfa3-diol
JPS556625B2 (de) 1974-05-16 1980-02-18
US4063025A (en) * 1975-02-05 1977-12-13 Yamanouchi Pharmaceutical Co., Ltd. 4-Substituted amino-α-aminomethylbenzyl alcohol derivatives
SE7510988L (sv) 1975-10-01 1977-04-02 Draco Ab Nya farmaceutiskt aktiva foreningar
DE2710997C3 (de) * 1977-03-14 1980-08-14 Dr. Karl Thomae Gmbh, 7950 Biberach 4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
MY8700026A (en) 1987-12-31
IE51373B1 (en) 1986-12-10
YU86483A (en) 1983-12-31
SU1128830A3 (ru) 1984-12-07
HK5385A (en) 1985-01-25
KR850000301B1 (ko) 1985-03-18
NO1996008I1 (no) 1996-06-27
ES513108A0 (es) 1983-02-16
CY1273A (en) 1985-03-08
PH16535A (en) 1983-11-10
PT73336A (en) 1981-08-01
YU43169B (en) 1989-04-30
YU43168B (en) 1989-04-30
AU7261881A (en) 1982-01-14
KR850002740A (ko) 1985-05-15
HU184959B (en) 1984-11-28
YU170481A (en) 1983-12-31
NO812311L (no) 1982-01-11
PL128513B1 (en) 1984-02-29
AU539976B2 (en) 1984-10-25
KR830006174A (ko) 1983-09-20
DK303481A (da) 1982-01-10
NO152130C (no) 1985-08-07
US4451663A (en) 1984-05-29
EP0043807B1 (de) 1984-05-30
DK157678C (da) 1990-06-18
GR74291B (de) 1984-06-21
PH19447A (en) 1986-04-18
NO152130B (no) 1985-04-29
IE811522L (en) 1982-01-09
FI73666B (fi) 1987-07-31
PT73336B (en) 1983-09-01
CS221845B2 (en) 1983-04-29
NZ197628A (en) 1985-07-12
KR850002741A (ko) 1985-05-15
HU187611B (en) 1986-02-28
EP0043807A3 (en) 1982-09-22
CA1180021A (en) 1984-12-27
IS1262B6 (is) 1987-03-27
ES513109A0 (es) 1983-03-01
KR850000871B1 (ko) 1985-06-22
US4419364A (en) 1983-12-06
EP0043807A2 (de) 1982-01-13
ES8304534A1 (es) 1983-03-01
DK157678B (da) 1990-02-05
FI812158L (fi) 1982-01-10
ES8304072A1 (es) 1983-02-16
PL232108A1 (de) 1982-08-02
YU42116B (en) 1988-04-30
LU88304I2 (fr) 1994-05-04
IS2657A7 (is) 1982-01-10
DE3163871D1 (en) 1984-07-05
ES8300678A1 (es) 1982-11-01
ES503768A0 (es) 1982-11-01
YU86383A (en) 1983-12-31
MX9203239A (es) 1992-07-01
FI73666C (fi) 1987-11-09
KR850000870B1 (ko) 1985-06-22
SG79784G (en) 1985-04-26
DD202001A5 (de) 1983-08-24

Similar Documents

Publication Publication Date Title
ATE7689T1 (de) 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
SE8303013D0 (sv) B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
IE832680L (en) Nitrosourea derivatives.
ES8305304A1 (es) "procedimiento de preparacion de derivados de etanolamina".
TH364EX (th) สารประกอบชนิดใหม่ซึ่งมีประโยชน์ในการรักษาโรค(กรรมวิธี)
TH364A (th) สารประกอบชนิดใหม่ซึ่งมีประโยชน์ในการรักษาโรค(กรรมวิธี)